ABT vs GEHC: fair value comparison
Abbott Laboratories and GE HealthCare Technologies Inc. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, GEHC currently sits closer to the top of our discount ranking. ABT carries the stronger quality grade.
| ABT | GEHC | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $101.95 | $63.93 |
| 12-month range | $87.78–$128.01 | $61.03–$82.82 |
| Sector rank | #35 of 113 Healthcare | #30 of 113 Healthcare |
| Quality grade | B | F |
| Momentum grade | — | B |
| Leverage | Moderate | Moderate |
| Margin trend | Expanding | Expanding |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | — | Downtrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The lower-middle quarter | The bottom quarter |
Full single-stock breakdowns: ABT fair value analysis · GEHC fair value analysis